The solution is here — in your DNA
Genetic factors can account for up to 95% of drug-response variability and susceptibility.3 In other words, how a drug will—or won't—work for a particular individual. Our RightMed® test brings pharmacogenomics to everyone, identifying how a patient's DNA and current medications may affect their response to drugs. OneOme: making prescriptions personal.
Healthcare of the future.
Cost-effective, comprehensive, personalized pharmacogenomic analysis — integrated into patients' everyday clinical care.
OneOme helps healthcare providers choose the optimal drug therapy the first time, thanks to targeted and evidence-based inputs using each patient's DNA and current prescriptions.
Swab. Send. Know.
Ordered by your physician, the OneOme RightMed pharmacogenomic test identifies which prescription drugs are—or aren’t—likely to work based on your genetic makeup and current prescription interactions. Your physician will receive a clear, actionable report for personalizing your prescriptions.
The latest at OneOme
Minneapolis, Minnesota; North Bay, Ontario (July 26, 2017) – A new partnership between OneOme and ProZed Pharmacy Solutions brings the power of personalized medicine to Canada.Minnesota-based OneOme will provide its RightMed® pharmacogenomics platform exclusively to customers of ProZed Pharmacy Solutions ...
In this webinar, we will walk through the newly released product updates and enhancements, including the:
● identify the genes that impact the metabolism and activity of opioid and non-opioid analgesics
● discuss how pharmacogenomic variants can affect the safety of pain management medications
● evaluate clinical studies investigating pharmacogenomic testing in treating postoperative pain, cancer-related pain, and pain in pediatrics
MINNEAPOLIS (June 15, 2017) – OneOme today launched a product update that makes improvements to its RightMed® pharmacogenomic test workflow, report and interactive application. OneOme’s updates incorporate customer feedback to optimize its product, with the goal of bringing the power of pharmac...
WEBINARS & EVENTS
OneOme will exhibit at Genetics & Genomics: A focus on Women's Health, September 7th in Cleveland, OH.
MINNEAPOLIS (May 31, 2017) – Pharmacogenomic company OneOme announced today it is working with leading health institutions on the nation’s largest population-based pharmacogenomics study. Pharmacogenomics is an emerging field that combines the study of how drugs affect our bodies (pharmacology)...
WEBINARS & EVENTS
MSHP Midyear Clinical Meeting 2017
OneOme will exhibit at the MSHP Midyear Clinical Meeting 2017, September 22nd in Brooklyn Center, MN.
“Before OneOme, only those with deep financial resources or the critically ill could
access the power of pharmacogenomics. Today, patients at Ridgeview can receive
personalized prescription insights that previously were inaccessible to them. Not only
will our patients see better health outcomes – they are also avoiding life-threatening
adverse drug reactions, which are the fourth leading cause of death.”
- Bob Stevens, President and CEO of Ridgeview Medical Center